TAYLOR NIELSEN: Open Payments
NPI 1548997349 · BEDFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 36 payments from 11 companies in 2025. Trend: 2023 $98 · 2024 $804 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 14 | $238 |
| Sumitomo Pharma America, Inc. | 4 | $68 |
| Astellas Pharma US Inc | 3 | $56 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $56 |
| MILLICENT US INC | 3 | $53 |
| Organon LLC | 2 | $35 |
| Exeltis, USA Inc. | 2 | $30 |
| Evofem Biosciences, Inc. | 2 | $27 |
| SHIELD THERAPEUTICS INC | 1 | $23 |
| Exact Sciences Corporation | 1 | $18 |
Products named: ZURZUVAE, Veozah, FEMLYV, MYFEMBREE, NEXPLANON, SLYND, Phexxi, ACCRUFER.
Industry payments across TX — which companies pay providers there.
